Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

448 public trials 58 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

XIENCE 28 USA Study

NCT03815175

Conditions
Anemia, Arterial Occlusive Diseases, Arteriosclerosis, +30 more
Locations
  • Heart Center Research, LLC Huntsville, Alabama, United States
  • Phoenix Cardiovascular Research Group Phoenix, Arizona, United States
  • Scottsdale Healthcare Shea Scottsdale, Arizona, United States
  • NEA Baptist Clinic Jonesboro, Arkansas, United States
View all 111 locations
View Trial Details
Completed

A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors

NCT03417245

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Investigational Site Number 0140 Little Rock, Arkansas, United States
  • Investigational Site Number 128 Gainesville, Florida, United States
  • Investigational Site Number 103 Tampa, Florida, United States
  • Investigational Site Number 102 Chicago, Illinois, United States
View all 64 locations
View Trial Details
Completed

A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors

NCT03417102

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Investigational Site Number 0117 Phoenix, Arizona, United States
  • Investigational Site Number 0139 Los Angeles, California, United States
  • Investigational Site Number 0135 Orange, California, United States
  • Investigational Site Number 0137 San Diego, California, United States
View all 58 locations
View Trial Details
Completed

PCR Based Detection of Azole Resistance in A. Fumigatus to Improve Patient Outcome.

NCT03121235

Conditions
Agranulocytosis, Aspergillosis, Aspergillosis, Invasive Pulmonary, +15 more
Locations
  • Academisch Medisch Centrum Amsterdam, Netherlands
  • VU Medisch Centrum Amsterdam, Netherlands
  • Universitair Medisch Centrum Groningen Groningen, Netherlands
  • Leids Universitair Medisch Centrum Leiden, Netherlands
View Trial Details
Completed

Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF

NCT01423851

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +14 more
Locations
  • Mayo Clinic Scottsdale Recruiting Scottsdale, Arizona, United States
  • UC San Diego Moores Cancer Center San Diego, California, United States
  • Mayo Clinic, Jacksonville Jacksonville, Florida, United States
  • Northwestern University Chicago, Illinois, United States
View Trial Details
Completed

Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma

NCT03111992

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Novartis Investigative Site Freiburg im Breisgau, Germany
  • Novartis Investigative Site Heidelberg, Germany
View Trial Details

Related conditions